Could a longer chemo infusion help patients with low muscle mass?
NCT ID NCT05183126
First seen Mar 07, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study looks at whether giving a longer infusion of the chemotherapy drug paclitaxel to cancer patients with low muscle mass can make drug levels in their blood more like those in patients with normal muscle mass. About 22 women with breast, stomach, or esophageal cancer will take part. The goal is to find a safer and more effective way to give this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Conditions
Explore the condition pages connected to this study.